AllisonBethanneReissMD

PubMed

• Editorial: Insights in Alzheimer's disease and related dementias.
  Agustín Ibáñez, Allison B Reiss, Nilton Custodio, Suvarna Alladi> ;Frontiers in Aging Neuroscience. 2022 Jan 1
• The physician's Alzheimer's disease management guide: Early detection and diagnosis of cognitive impairment, Alzheimer's disease and related dementia.
  Allison B Reiss, Donna de Levante Raphael, Nathaniel A Chin, Vivek Sinha> ;AIMS Public Health. 2022 Jan 1
• Hydroxychloroquine Effects on THP-1 Macrophage Cholesterol Handling: Cell Culture Studies Corresponding to the TARGET Cardiovascular Trial.
  Saba Ahmed, Justin Konig, Lora J Kasselman, Heather A Renna, Joshua De Leon, Steven E Carsons, Allison B Reiss> ;Medicina. 2022 Sep 16
• 2 citations
  The role of massive demographic databases in intractable illnesses: Denomics for dementia.
  Mark M Stecker, Morgan R Peltier, Allison B Reiss> ;AIMS Public Health. 2022 Jan 1
• 1 citations
  Special Issue on "Advances in Cholesterol and Lipid Metabolism".
  Allison B Reiss, Joshua De Leon> ;Metabolites. 2022 Aug 19
• 6 citations
  Plants, Plants, and More Plants: Plant-Derived Nutrients and Their Protective Roles in Cognitive Function, Alzheimer's Disease, and Other Dementias.
  Helen Ding, Allison B Reiss, Aaron Pinkhasov, Lora J Kasselman> ;Medicina. 2022 Jul 30
• 2 citations
  Dementia and Diet, Methodological and Statistical Issues: A Pilot Study.
  Mark Stecker, Mona Stecker, Allison B Reiss, Lora Kasselman> ;Frontiers in Aging Neuroscience. 2022 Jan 1
• 9 citations
  Mild-to-Moderate Traumatic Brain Injury: A Review with Focus on the Visual System.
  Steven H Rauchman, Jacqueline Albert, Aaron Pinkhasov, Allison B Reiss> ;Neurology International. 2022 May 30
• Methotrexate effects on adenosine receptor expression in peripheral monocytes of persons with type 2 diabetes and cardiovascular disease.
  Allison Bethanne Reiss, Isaac Teboul, Lora Kasselman, Saba Ahmed, Steven E Carsons, Joshua De Leon> ;Journal of Investigative Medicine. 2022 Aug 1
• 2 citations
  Cognitive changes mediated by adenosine receptor blockade in a resveratrol-treated atherosclerosis-prone lupus mouse model.
  Lora J Kasselman, Heather A Renna, Iryna Voloshyna, Aaron Pinkhasov, Irving H Gomolin, Isaac Teboul, Joshua De Leon, Steven E Carsons, Allison B Reiss> ;Journal of Traditional and Complementary Medicine. 2022 Sep 1
• 77 citations
  Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target.
  Saba Ahmed, Ailin Elyasi, Lora J. Kasselman, Joshua De Leon, Amy D Glass, Allison B. Reiss> ;Metabolites. 2021 Oct 8
• 7 citations
  Cardiovascular Disease Complicating COVID-19 in the Elderly.
  Joshua De Leon, Allison B. Reiss, Christopher Dayaramani> ;Medicina. 2021 Aug 17
• 14 citations
  Understanding Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Toward Better Treatment and Prevention
  Allison B. Reiss, Benna Jacob, Saba Ahmed, Steven E. Carsons, Joshua DeLeon> ;Inflammation. 2021 Apr 5
• 17 citations
  Alzheimer Disease Clinical Trials Targeting Amyloid: Lessons Learned From Success in Mice and Failure in Humans.
  Allison B. Reiss, Natalie Montufar, Joshua DeLeon, Aaron Pinkhasov, Irving H. Gomolin, Amy D Glass, Hirra A Arain, Mark M. Stecker> ;The Neurologist. 2021 Mar 4
• 2 citations
  Effect of oxytocin on lipid accumulation under inflammatory conditions in human macrophages.
  Ariel Karten, Heather A. Renna, Steven E. Carsons, Joshua DeLeon, Aaron Pinkhasov, Irving H. Gomolin, Daniel S. Glass, Allison B. Reiss, Lora J. Kasselman> ;Experimental and Molecular Pathology. 2021 Feb 1
• 11 citations
  A Telemedicine Approach to Covid-19 Assessment and Triage.
  Allison B. Reiss, Joshua De Leon, Isaac P. Dapkins, George Shahin, Morgan R. Peltier, Eric R. Goldberg> ;Medicina. 2020 Sep 10
• 28 citations
  The role of interferon-γ in cardiovascular disease: an update.
  Ailin Elyasi, Iryna Voloshyna, Saba Ahmed, Lora J. Kasselman, Jennifer Behbodikhah, Joshua De Leon, Allison B. Reiss> ;Inflammation Research. 2020 Jul 22
• 14 citations
  Alzheimer’s disease: many failed trials, so where do we go from here?
  Allison B. Reiss, Amy D Glass, Thomas Wisniewski, Benjamin Wolozin, Irving H. Gomolin, Aaron Pinkhasov, Joshua De Leon, Mark M. Stecker> ;Journal of Investigative Medicine. 2020 Aug 1
• 54 citations
  Idiopathic pulmonary fibrosis: Molecular mechanisms and potential treatment approaches.
  Daniel S. Glass, David Grossfeld, Heather A. Renna, Priya Agarwala, Peter Spiegler, Lora J. Kasselman, Amy D Glass, Joshua DeLeon, Allison B. Reiss> ;Respiratory Investigation. 2020 Sep 1
• 1 citations
  The gut microbiome and psycho-cognitive traits.
  Neal Shah, Eric Lam, Pamela Herd, Allison B. Reiss, Lora J. Kasselman> ;Progress in Molecular Biology and Translational Science. 2020 Jan 1
• 54 citations
  Adenosine and the Cardiovascular System.
  Allison B. Reiss, David Grossfeld, Lora J. Kasselman, Heather A. Renna, Nicholas A. Vernice, Wendy Drewes, Justin Konig, Steven E. Carsons, Joshua DeLeon> ;American Journal of Cardiovascular Drugs. 2019 Oct 1
• 5 citations
  Human Lupus Plasma Pro-Atherogenic Effects on Cultured Macrophages Are Not Mitigated by Statin Therapy: A Mechanistic LAPS Substudy.
  Allison B. Reiss, Hirra A Arain, Lora J. Kasselman, Heather A. Renna, Juan Zhen, Iryna Voloshyna, Joshua DeLeon, Steven E. Carsons, Michelle Petri> ;Medicina. 2019 Aug 21
• 28 citations
  Cholesterol efflux alterations in adolescent obesity: role of adipose-derived extracellular vesical microRNAs
  Matthew D. Barberio, Lora J. Kasselman, Martin P. Playford, Samuel B. Epstein, Heather A. Renna, Madeleine Goldberg, Joshua DeLeon, Iryna Voloshyna, Ashley Barlev, Mic...> ;Journal of Translational Medicine. 2019 Jul 22
• 14 citations
  Oxytocin: Potential to mitigate cardiovascular risk.
  Allison B. Reiss, Daniel S. Glass, Eric Lam, Amy D Glass, Joshua De Leon, Lora J. Kasselman> ;Peptides. 2019 May 18
• 8 citations
  Macrophage lipid accumulation in the presence of immunosuppressive drugs mycophenolate mofetil and cyclosporin A.
  Iryna Voloshyna, Isaac Teboul, Lora J. Kasselman, Michael Salama, Steven E. Carsons, Joshua DeLeon, Joseph Mattana, Nobuyuki Miyawaki, Allison B. Reiss> ;Inflammation Research. 2019 Jun 21
• Join now to see all

Journal Articles

• Amyloid Toxicity in Alzheimer�s Disease  
  Reiss, A.B., Arain, H.A., Stecker, M.M., Siegart, N.M., Kasselman, L.J., Rev. Neurosci., 1/1/2018
• The Gut Microbiome and Elevated Cardiovascular Risk in Obesity and Autoimmunity  
  Kasselman, L.J., Vernice, N.A., De Leon, J., Reiss, A.B., Atherosclerosis, 1/1/2018
• PCSK9 in cholesterol metabolism: from bench to bedside  
  Reiss, A.B., Shah, N., Muhieddine, D., Zhen, J., Yudkevich, J., Kasselman, L.J., DeLeon, J., Clin Sci (Lond), 1/1/2018
• Accelerated Atherosclerosis in the Setting of Chronic Kidney Disease  
  Reiss, A.B., Glass, A.D., Renna, H.A., Grossfeld, D.J., Glass, D.S., Kasselman, L.J., De Leon, J, Archives of Nephrology., 1/1/2018
• Amyloidosis and the Kidney  
  Reiss, A.B., Siegart, N.M., Renna, H.A., De Leon, J., Kasselman, L.J., Miyawaki, N., The Scientific Pages of Nephrology, 1/1/2017
• Exosomes in Cholesterol Metabolism and Atherosclerosis Cardiovasc Hematol Disord Drug Targets  
  Reiss, A.B., Vernice, N.A., Siegart, N.M., De Leon, J., Kasselman, L.J., Cardiovasc Hematol Disord Drug Targets., 1/1/2017
• COX-2-dependent and independent effects of COX-2 inhibitors and NSAIDs on proatherogenic changes in human monocytes/macrophages  
  Voloshyna, I., Kasselman, L.J., Carsons, S.E., Littlefield, M.J., Gomolin, I.H., De Leon, J., Reiss, A.B., J Investig Med., 1/1/2017
• Interleukin-6 in atherosclerosis: atherogenic or atheroprotective?  
  Reiss, A.B., Siegart N.M., DeLeon, J., Clinical Lipidology., 1/1/2017
• Effect of inhibition of IL-12/23 by ustekinumab on the expression of leptin and leptin receptor in human THP-1 macrophages  
  Voloshyna, I., Mounessa, J., Carsons, S.E., Reiss, A.B., Clin Exp Dermatol., 1/1/2016
• The Adenosine A2A Receptor Agonist UK-432,097 Stimulates Expression of Anti-Atherogenic Reverse Cholesterol Transport Proteins  
  Reiss, A.B., Moosa, S., Siegart, N.M., Kasselman, L.J., Rob, S., Carsons, S.E., DeLeon, J., Voloshyna, I., JCvD, 1/1/2016
• Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol efflux  
  Voloshyna, I., Teboul, I., Littlefield, M.J., Siegart, N.M., Turi, G.K., Fazzari, M.J., Carsons, S.E., DeLeon, J., Reiss, A.B., Exp Biol Med (Maywood)., 1/1/2016
• Intensive versus Standard Therapy for Hypertension: The Clinical Trials  
  Shah, N., Siegart, N.M., De Leon, J., Reiss, A.B., J Hypertens Manag, 1/1/2016
• Plasma IL-33 in atopic patients correlates with pro-inflammatory cytokines and changes cholesterol transport protein expression: a surprising neutral overall impact on...  
  Voloshyna, I., Mucci, T., Sher, J., Fonacier, L.S., Littlefield, M.J., Carsons, S., Reiss, A.B., Clin Exp Allergy., 1/1/2015
• Cholesterol Metabolism in Chronic Kidney Disease  
  Reiss, A.B., Voloshyna, I., Deleon, J., Miyawaki, N., Mattana, J., Am J Kidney Dis., 1/1/2015
•  
  Voloshyna, I., Littlefield, M.J., and Reiss, A.B., Trends in Cardiovascular Medicine, 1/1/2014
• Infliximab Reverses Suppression of Cholesterol Efflux Proteins by TNF-alpha: A Possible Mechanism for Modulation of Atherogenesis  
  Voloshyna, I., Seshadri, S., Anwar, K., Littlefield, M.J., Belilos, E., Carsons, S.E., Reiss, A.B., BioMed Research International, 1/1/2014
• Advanced Glycation End Products Promote Pro-atherogenic Changes in Cholesterol Transport: A Possible Mechanism for Cardiovascular Risk  
  Voloshyna, I., Gamez-Godoy, J., Littlefield, M., De Leon, J., Castro-Magana, M., Reiss, A.B., Intern Med., 1/1/2014
• Polarization of Human THP-1 Macrophages: Link between Adenosine Receptors, Inflammation and Lipid Accumulation  
  Littlefield, M.J., Teboul, I., Voloshyna, I., Reiss, A.B., J Immunol Immunother, 1/1/2014
•  
  Voloshyna, I., Hai, O., Littlefield, M.J., Carsons, S.E., and Reiss, A.B., Eur. J. Pharmacol, 1/1/2013
• Adenosine A(2A) receptor activation supports an atheroprotective cholesterol balance in human macrophages and endothelial cells  
  Voloshyna, I., Carsons, S., Littlefield, M.J., Rieger, J.M., Figler, R., and Reiss, A.B., Biochim. Biophys. Acta., 1/1/2013
• Plasma from Rheumatoid Arthritis Patients Promotes Pro-atherogenic Cholesterol Transport Gene Expression in THP-1 Human Macrophages  
  Voloshyna, I., Modayil, S., Littlefield, M.J., Belilos, E., Belostocki, K.B., Bonetti, L., Rosenblum, G.C., Carsons, S.E., Reiss, A.B., Exp. Biol. Med. (Maywood)., 1/1/2013
• Regulation of foam cells by adenosine  
  Reiss, A.B., Cronstein, B.N., Arterioscler Thromb Vasc Biol., 1/1/2012
• Regulation of cerebral cholesterol metabolism in Alzheimer�s disease  
  Reiss, A.B., Voloshyna, I., J. Investig. Med., 1/1/2012
• Resveratrol in cholesterol metabolism and atherosclerosis  
  Voloshyna, I., Hussaini, S.M., and Reiss, A.B., J. Med. Food., 1/1/2012
• Oxysterol derivatives of cholesterol in neurodegenerative disorders  
  Jeitner, T.M., Voloshyna, I., and Reiss, A.B., Curr. Med. Chem., 1/1/2011
• Join now to see all

Books/Book Chapters

• Cytochrome P450 Enzymes: Biochemistry, Pharmacology and Health Implications. 
  Chapter: Cytochrome P450 Enzymes in Atherosclerosis 
  Page 87.0 - 107.0Voloshyna, I., and Reiss, A.B.Editors: Jian Wu.Nova Science Publishers2014
• Adenosine Receptors: Therapeutic Aspects for Inflammatory and Immune Diseases. 
  Chapter: Adenosine in Atherosclerosis 
  Page 313.0 - 325.0Reiss, A.B.Editors: Hasko, G., Cronstein, B.N., and Csaba S.CRC Press.2007
• Proteins Involved in the Pathogenesis of Atherosclerosis 
  Chapter: Scavenger Receptors that Mediate Uptake of Oxidized Low-Density Lipoprotein and Foam Cell Formation 
  Page 1.0 - 12.0Reiss, A.B., and Glass, A.D. CD36 and ScR-AEditors: Reiss, A.B., Carsons, S., and Cronstein, B.N..Research Signpost2006
• Proteins Involved in the Pathogenesis of Atherosclerosis. 
  Chapter: Matrix Proteases in Atherosclerosis 
  Page 139.0 - 149.0Chan, E.S.L., Fernandez, P., Zhang, H., and Reiss, A.B.Editors: Reiss, A.B., Carsons, S., and Cronstein, B.N..Research Signpost.2006
• Lupus: Molecular and Cellular Pathogenesis. 
  Chapter: The vascular endothelium, a new actor in the pathogenesis of vascular injury in sysyemic lupuserythematosis. 
  Cronstein, B.N., Reiss, A.B., and Malhotra, S.Editors: Kammer, G.M..1998
• Join now to see all

Abstracts/Posters

• Microglia in a Hyperglycemic Environment Promote Alzheimer's Disease-Like Pathology through Cholingergic Synaptic Dysfunction and Increased Amyloid beta Production.
  Arain HA, Renna HA, Kasselman LJ, Pinkhasov A, Gomolin I, Jacobson AM, De Leon J, Fazzari MJ, Reiss AB., J Investig Med, 1/1/2018
• The Effect of B-hydroxybutyrate on Human Microglia: Implications for the Ketogenic Diet in Neurodegenerative Disorders.
  Kasselman LJ, Chevalier C, Zhen J, Grossfeld D, Pinkhasov A, Gomolin I, Reiss AB, J Investig Med, 1/1/2018
• Atherosclerosis in Autoimmune Rheumatic Diseases: Comparison of Plasma Effects on Macrophage Cholesterol Balance in vitro, and Correlation to Traditional Cardiovascula...
  Maidhof A, Kasselman LJ, Carsons S, Belilos E, Belostocki K, Rosenblum G, Bonetti L, Fazzari M, DeLeon J, Reiss AB, J Investig Med, 1/1/2018
• Evaluation of Biologic Therapy versus Triple DMARD Therapy in RA Patients Unresponsive To Methotrexate.
  Vernice NA, Reiss AB, Renna HA, De Leon J, Carsons S, Kasselman LJ, J Investig Med., 1/1/2018
• Exploring Abnormalities in Lung MicroRNAs in Idiopathc Pulmonary Fibrosis using Exhaled Breath Condensate
  Pletukhina N, Kasselman LJ, Salzman SH, Renna HA, Reiss AB, Agarwala P., J Investig Med., 1/1/2018
• Novel Insight into Impaired Cholesterol Transport in Chronic Kidney Disease: Demonstration of Reversibility with Vitamin D and ACE-Inhibitor
  Daccueil F, Siegart NM, Reiss AB, Renna HA, Arain HA, Kasselman LJ, Mattana J, De Leon J, Miyawaki N., J Invest Med, 1/1/2017
• Adipocyte-derived Exosomes from Obese Subjects have Atherogenic Effects on Cholesterol Efflux in THP-1 Human Macrophages.
  Siegart NM, Reiss AB, De Leon J, Voloshyna I, Barlev A, Salama M, Ferrante S, Nadler E, Freishtat RJ., J Invest Med., 1/1/2017
• Peripheral Blood Mononuclear Cells of CIRT Patients Maintain Their Adenosine A2A Receptors in the Presence of Low Dose Methotrexate.
  Teboul I, Reiss AB, Siegart NM, Kasselman LJ, Carsons SE, De Leon J, J Invest Med., 1/1/2017
• Statins Were Not Effective in Promoting Cholesterol Balance In Human Macrophages Treated with Systemic Lupus Erythematosus Plasma: A Gene Expression Analysis and Impli...
  Arain HA, Petri M, Kasselman LJ, Siegart NM, Renna HA, Carsons SE, De Leon J, Reiss AB., J Invest Med., 1/1/2017
• Blockade of the Receptor for Advanced Glycation End Products is Not Sufficient to Prevent Atherogenic Disruption of Lipid Metabolism by Plasma from Type 1 Diabetes Pat...
  Accacha S, Reiss AB, Mejia-Corletto J, Siegart NM, Renna HA, Castro-Magana M, De Leon J, Kasselman LJ., J Invest Med., 1/1/2017
• Pro-atherogenic properties of plasma from patients with type 1 diabetes mellitus: effects on macrophage lipid handling.
  De Leon JR, Mejia Corletto J, Accacha S, Voloshyna I, Siegart S, Kasselman L, Castro Magana M, Reiss A., J Am Coll Cardiol., 1/1/2017
• Inhibition of the Receptor for Advanced Glycation End Products Restores Cholesterol Efflux in THP-1 Human Macrophages Exposed to Plasma from Type 1 Diabetes Mellitus P...
  Mejia Corletto, J., Accacha, S., Voloshyna, I., Siegart, N., Kasselman, L., Castro Magana, M., De Leon, J., Reiss, A.B., J Invest Med, 1/1/2016
• Cholesterol Flux Pathway Abnormalities Induced by Plasma from Patients with Chronic Kidney Disease
  Miyawaki, N., Daccueil, F., Siegart, N.M., Mattana, J., Voloshyna, I., Kasselman, L.J., De Leon, J., Reiss, A.B., J Invest Med., 1/1/2016
• The Adenosine A2A Receptor Agonist UK-432,097 Stimulates Anti-Atherogenic Reverse Cholesterol Transport Proteins in THP-1 Human Macrophages.
  Moosa, S., Voloshyna, I., Siegart, N.M., De Leon, J., Carsons, S.E., Kasselman, L.J., Littlefield, M.J., Reiss, A.B., J Invest Med., 1/1/2016
• Correcting Atherogenic Effects of Lupus Plasma on Macrophages with Resveratrol and Mycophenolate.
  Siegart, N.M., Voloshyna, I., De Leon, J., Carsons, S.E., Teboul, I., Kasselman, L.J., Mattana, J., Reiss, A.B., J Invest Med, 1/1/2016
• Comparative Effect of Selective and Non-Selective Cox-2 Inhibitors on Lipid Accumulation in Human Macrophages.
  Kasselman, L.J., Voloshyna, I., Littlefield, M.J., Siegart, N., Carsons, S.E., Gomolin, I., De Leon, J., Reiss, A.B., J Invest Med, 1/1/2016
• BMI-dependent effects of adipose tissue exosomes on human macrophage cholesterol transport gene expression.
  Reiss, A.B., DeLeon, J., Voloshyna, I., Ferrante, S., Siegart, N., Barlev, A., Littlefield, M., Salama, M., Kasselman, L.J., Freishtat, R., J Am Coll Cardiol, 1/1/2016
• Abnormalities in Cholesterol Flux Pathway Induced by Plasma from Patients with Chronic Kidney Disease.
  Daccueil F, Reiss AB, Siegart NM, Mattana J, Voloshyna I, Kasselman L, De Leon J, Miyawaki N., J Am Soc Nephrol., 1/1/2016
• Novel Mechanism for Cardiovascular Protective Effect of Vitamin D and ACE inhibitors in Chronic Kidney Disease: Correction of Impaired Cholesterol Efflux Induced by Pl...
  Miyawaki N, Siegart NM, Renna HA, Arain HA, Daccueil F, Mattana J, De Leon J, Reiss AB., J Am Soc Nephrol, 1/1/2016
• Atherogenic Impact of Adipocyte Exosomes from Obese Adolescents on Human Macrophage Cholesterol Handling: A Potential Mechanism Linking Excess Weight and Cardiovascula...
  Reiss AB, De Leon J, Siegart NM, Voloshyna I, Ferrante S, Barlev A, Nadler EP, Salama M, Kasselman LJ, Freishtat RJ., Obesity Week, 1/1/2016
• Fc gamma-Fragment and IgG Monoclonal Antibody Polarization of�Human Macrophages; A Novel Immunomodulatory Mechanism.
  Steele RA, Littlefield MJ, Voloshyna I, Davis-Lorton MA, Aquino MR, Fonacier LS, Reiss AB, J Allergy Clin Immunol., 1/1/2015
• Immunosuppressive Drugs Mycophenolate Mofetil and Cyclosporin A: Disparate Effects on Atherogenic Lipid Accumulation in THP-1 Human Macrophages
  Salama, M., Voloshyna, I., Littlefield, M.J., Teboul, I., De Leon, J., Carsons, S.E., Mattana, J., Reiss, A.B., J Invest Med, 1/1/2015
• Do Classically Activated M1 Macrophages Display Pro-Atherogenic Changes in Cholesterol Transport Proteins?
  Wallace, M.B., Voloshyna, I., Teboul, I., Littlefield, M.J., De Leon, J., Reiss, A.B., J Invest Med, 1/1/2015
• Role of Adenosine A2A and A3 Receptors in Macrophage Polarization: Link between Inflammation and Lipid Accumulation.
  Teboul, I., Voloshyna, I., Littlefield, M., Mattana, J., De Leon, J., Reiss, A.B., J Invest Med., 1/1/2015
• Obesity and Atherosclerosis: Exosome Effect on Cholesterol Efflux in THP-1 Human Macrophages.
  Barlev, A., Voloshyna, I., Ferrante, S.C., Salama, M., Littlefield, M.J., Reiss, A.B., Freishtat, R.J., J Invest Med., 1/1/2015
• Join now to see all

Lectures

• Building Your Career: Getting Published in High Quality Biomedical Journals 
  1/1/2010
• Immune Complexes Contribute to the Development of Atherosclerosis in Patients with SLE. 
  1/28/1997
• Immune Complexes in Atherosclerosis. 
  1/17/1997
• Occupancy of C1q Receptors on Endothelial Cells by Immune Complexes Downregulates mRNA for Sterol 27-Hydroxylase, the Major Mediator of Extra-hepatic Cholesterol Metab... 
  San Diego - 1/8./1998
• C1q Receptors and their Role in Atherogenesis in SLE. 
  New York City - 1/11/1999
• New York City. Premature Atherosclerosis in Systemic Lupus Erythematosus 
  Long Island University - 1/3./2000
•  
  Harriman, New York - 1/7./2000
• Regulation of Cholesterol 27-Hydroxylase in the Pathogenesis of Atherosclerosis in SLE. 
  New York University School of Medicine - 1/8./2001
• Cholesterol 27-Hydroxylase in the Pathogenesis of Atherosclerosis in SLE. 
  SUNY-Downstate Medical Center - 1/3./2001
• Immunological Mechanisms in Premature Atherosclerosis. 
  The New York Academy of Medicine - 1/24/2001
• Serum from SLE Patients Compromises Cholesterol Homeostasis in Cultured Human Aortic Endothelial Cells (HAEC) by Decreasing Cholesterol 27-Hydroxylase Expression. 
  Bethesda, MD - 1/10/2002
• A Potential Immunological Basis for Premature Atherosclerosis in Patients with Systemic Lupus Erythematosus. 
  University of California, Los Angeles - 1/23/2002
• Serum from SLE Patients Compromises Cholesterol Homeostasis in Cultured Human Aortic Endothelial Cells (HAEC) by Decreasing Cholesterol 27-Hydroxylase Expression 
  1/12/2003
• Immunomodulation of Cholesterol Flux in the Pathogenesis of Atherosclerosis. 
  1/13/2003
• Immunologically Mediated Disruptions in Cholesterol Flux in the Pathogenesis of Atherosclerosis and Alzheimer�s Disease. 
  1/2./2004
• Pathogenesis of Accelerated Atherosclerosis in Lupus: Immune Reactant-induced Disruption of Cholesterol Flux in the Arterial Wall 
  New York, NY - 1/10/2004
• Adenosine A2A receptor activation counteracts atherogenic effects of immune reactants on cholesterol flux in macrophages 
  New Orleans, LA - 1/10/2004
• The Immune System in Atherosclerosis: Influence on Cholesterol Metabolism Basic Research with Clinical Applications 
  1/24/2004
• Atherosclerosis: Immune and Inflammatory Aspects 
  San Diego, CA - 1/4./2005
• The Immune System in Atherosclerosis: Influence on Cholesterol Metabolism. 
  1/5./2005
• COX-2 Inhibitors and Prostaglandin Pathways: Laboratory Science Explores Cardiovascular Effects 
  1/14/2006
• Unraveling Coxib Atherogenicity: Adenosine A2A Receptor Agonists Reverse Disruption of Cholesterol Efflux Induced by Cyclooxygenase (COX)-2 Inhibition 
  1/16/2006
• Lipid Abnormalities, the Immune System and Atherosclerosis 
  Division of Cardiology; Winthrop University Hospital - 1/31/2007
• Increased Risk of Heart Attack with Pain-relieving Medications: Disruption of Cholesterol Metabolism. 
  1/22/2007
• Inhibiting Cyclooxygenase with Coxibs and NSAIDs: Efficacy vs. Cardiovascular Risk 
  San Diego Convention Center, San Diego, CA - 1/8./2008
• Join now to see all